Investors

Media

Welcome to the new Regeneron Newsroom. This newsroom is designed to provide members of the media with easy access to up-to-date information about the Company.

For an e-mail response to questions about Regeneron, please contact us at media@regeneron.com.



Upcoming Events

May 8, 2014
8:30 AM ET
Webcast Regeneron Pharmaceuticals Q1 2014 Earnings Conference Call


View all releases Recent Press Releases

Apr 11, 2014 Regeneron to Report First Quarter 2014 Financial and Operating Results and Host Conference Call and Webcast on May 8, 2014
Apr 4, 2014 Robert A. Ingram Elected to Regeneron Board of Directors
Apr 3, 2014 Regeneron Announces Initiative for STEM Education in Hudson Valley
Apr 1, 2014 Sanofi and Regeneron Report Positive Results With Alirocumab From Phase 2 Japanese Study
Mar 27, 2014 Sanofi and Regeneron To Present Alirocumab Clinical Data at the American College of Cardiology's 63rd Annual Scientific Session
Mar 3, 2014 Bayer HealthCare and Regeneron Announce Regulatory Submission of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Japan
Feb 24, 2014 Regeneron Announces FDA Acceptance of EYLEA® (aflibercept) Injection Supplemental Biologics License Application for the Treatment of Macular Edema Following Branch Retinal Vein Occlusion
Feb 14, 2014 Regeneron Announces Upcoming 2014 Investor Conference Presentations
Feb 11, 2014 Regeneron Reports Fourth Quarter and Full Year 2013 Financial and Operating Results
Feb 10, 2014 Two-Year Results From Phase 3 VISTA Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision


Close
Form content here please :)